ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

In Washington: Health Groups Urge Congress: No Immunity For Tobacco Industry; Clinton Proposes $400M Effort To End Racial Health Disparities

February 27, 1998

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

Columbus CCP Forms New Entity to Administer CCOP

July 20, 1990